MORGAN STANLEY - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$682,236
+18.6%
821,972
+0.0%
0.00%
Q1 2023$575,165
+100.9%
821,665
+46.1%
0.00%
Q4 2022$286,273
-24.5%
562,423
-5.1%
0.00%
Q3 2022$379,000
-40.9%
592,461
-4.9%
0.00%
Q2 2022$641,000
-49.7%
622,892
-8.1%
0.00%
Q1 2022$1,274,000
-55.9%
678,120
+13.0%
0.00%
Q4 2021$2,891,000
-33.1%
600,003
+0.4%
0.00%
-100.0%
Q3 2021$4,321,000
-25.8%
597,508
-5.3%
0.00%0.0%
Q2 2021$5,824,000
+36.8%
631,008
+82.5%
0.00%0.0%
Q1 2021$4,256,000
-29.9%
345,671
-19.7%
0.00%0.0%
Q4 2020$6,067,000
+163.0%
430,284
+123.8%
0.00%
Q3 2020$2,307,000
+86.8%
192,228
+158.5%
0.00%
Q2 2020$1,235,000
+74.7%
74,369
+19.6%
0.00%
Q1 2020$707,000
+2180.6%
62,162
+2397.5%
0.00%
Q4 2019$31,000
+520.0%
2,489
+25.2%
0.00%
Q3 2019$5,0001,9880.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders